Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair
Enables you to alter patients’ disease progression and put them on the path to healing
Seamlessly integrates into your critical-care workflow
Critically ill patients in the ICU often face an alarming, urgent situation. A dangerous, dysregulated hyperinflammatory response to infection, trauma or surgery can lead to multiorgan failure and in severe cases, even death.
SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for.
Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives.
With SeaStar Medical’s novel, simple-to-use SCD technology, you can quickly rescue patients from this dysregulated immune response to restore immune balance and help the body return toward homeostasis.
A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly.
SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies provide life-saving solutions to critically ill patients. We are developing and commercializing cell-directed extracorporeal therapies that target the key immune cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
©SeaStar Medical 2023